US2015274639A1PendingUtilityA1
Methods of use for compositions comprising a biocidal polyamine
Est. expiryMay 22, 2033(~6.8 yrs left)· nominal 20-yr term from priority
Inventors:Dustin WilliamsRyan LooperSujeevini JeyapalinaTravis HaussenerPaul R. SebaharHari Kanna Reddy
A01N 43/84C07C 211/01C07D 213/64A01N 37/06C07C 225/12C07C 211/27C07C 211/09A61K 31/381A01N 37/18C07C 237/34C07C 211/14A61K 31/166C07C 211/11A61K 31/357A01N 37/30A61K 31/4418A01N 43/30A61L 12/14C07D 295/135A61K 31/5375C07C 271/20A61L 12/147A01N 33/10A01N 33/04C09D 5/1625A61K 31/135C07D 317/46C07C 233/78A01N 43/10A61K 31/325A01N 33/00A01N 43/40C07D 213/38C07D 317/58C07C 217/58C07C 217/54A61K 31/137C07D 333/20A01N 47/12A01N 33/02A01N 37/20
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, reduce biofilms, and/or inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms.
Claims
exact text as granted — not AI-modified1 . A method for dispersing or killing a biofilm, the method comprising a step of treating the biofilm with an anti-biofilm composition, thereby effectively dispersing or killing the biofilm;
wherein the anti-biofilm composition comprises a biocidal polyamine compound selected from the group consisting of:
and a salt thereof;
wherein:
each R a is a member independently selected from the group consisting of
A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , and A 9 are each an A n member independently selected selected from the group consisting of N, CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form a cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; wherein at least one A i member and at most five A n members are an independently selected CR a ;
each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; or, alternatively, an R 1a and an R 1b join to form an oxo group;
each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; alternatively, a pair of R 2 members from the same R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a member independently selected from the group consisting of spirocycloalkyl, spiroheterocycyl, and oxo; or, alternatively, an R 2a and an R 2c from the same R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl;
each R m is a member independently selected from the group consisting of —CR 2a R 2b —, —CR 2c R 2d —, —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—;
each m is an integer independently selected from 1 to 20;
each L 1 and L 2 is a member independently selected from the group consisting of a bond, —O—, —C(O)O—, —NR 4 —, —NR 4 C(O)—, and —C(O)NR 4 —;
each R 3 is a member independently selected from the group consisting of —Z—R 4 , —Z—Y 1 —R 4 , —Z—Y 1 —Y 2 —R 4 , and —Z—Y 1 —Y 2 —Y 3 —R 4 ;
each R 4 is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; or, alternatively, for a —N(R 4 ) 2 group, one of the two R 4 in the group is a member selected from the group consisting of —(CO)OR 6a —, (CO)N(R 6a )(R 6b ), and —C(NR 6a )N(R 6b )(R 6c );
each R 5 is a member independently selected from the group consisting of hydrogen, alkyl, hydroxyl, alkoxy, alkylamino, alkenyl, alkynyl, aryl, aryloxy, arylamino, cycloalkyl, cycloalkoxy, cycloalkylamino, heterocyclyl, heterocycyloxy, heterocycylamino, halo, haloalkyl, fluoroalkyloxy, heteroaryl, heteroaryloxy, heteroarylamino, arylalkyl, arylalkyloxy, arylalkylamino, heteroarylalkyl, heteroarylalkyloxy, heteroarylalkylamino; hydroxyalkyl, aminoalkyl, and alkylaminoalkyl;
each Y 1 , Y 2 , and Y 3 is an independently selected group of Formula IA:
each Z 1 and Z 2 is a member independently selected from the group consisting of NR 4 and O; and
each R 6a , R 6b , and R 6c is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, cycloalkyl, and heteroarylalkyl; or, alternatively, two R 6n members R 6a and R 6b or R 6a and R 6c form a heterocycyl ring;
wherein the biocidal polyamine compound comprises at least two primary or secondary amino groups.
2 . The method of claim 1 , wherein:
each R a is independently a group of Formula II:
each of the A n members is independently selected from the group consisting of CR a and CR 5 ; or, alternatively, a pair of adjacent A n members join to form a cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; wherein at least one A n member and at most three A n members are independently selected CR a ,
each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl;
for each R a member, at most two R m of the R a member are selected from the group consisting of —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—; and
each m is an integer independently selected from 1 to 16.
3 . The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of:
and a salt thereof;
wherein:
at least one A n member and at most three A n members are independently selected CR a ,
each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; alternatively, a pair of R 2n members from the R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a ring independently selected from the group consisting of spirocycloalkyl and spiroheterocycyl; or, alternatively, the R 2a and the R 2c from the R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl;
each m is an integer independently selected from 1 to 12;
each R 3 is a member independently selected from the group consisting of —Z—Y 1 —R 4 and —Z—Y 1 —Y 2 —R 4 ; and
each Z 1 and Z 2 is an independently selected NR 4 .
4 . The method of claim 1 , wherein:
A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 and A 9 are each an A n member independently selected selected from the group consisting of CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form a cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; each m is an integer independently selected from 1 to 10; each L 1 and L 2 is a member independently selected from the group consisting of a bond, —O—, and —NR 4 —; each R 3 is a member independently selected from the group consisting of —Z—R 4 , —Z—Y 1 —R 4 , and —Z—Y 1 —Y 2 —R 4 ; and each Z 1 and Z 2 is an independently selected NR 4 .
5 . The method of claim 4 , wherein the biocidal polyamine compound is selected from the group consisting of:
and a salt thereof;
wherein:
each R a is independently a group of Formula V:
each of the A n members is independently selected from the group consisting of CR a and CR 5 ; or, alternatively, a pair of adjacent A n members join to form a cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; wherein at least one A n member and at most three A n members are independently selected CR a ,
each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl;
for each R a member, at most two R m of the R a member are selected from the group consisting of —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—; and
each R 3 is a member independently selected from the group consisting of —Z—Y 1 —R 4 and —Z—Y 1 —Y 2 —R 4 .
6 . The method of claim 1 , wherein the biocidal polyamine compound comprises at least four primary or secondary amino groups.
7 . The method of claim 1 , wherein the biocidal polyamine compound comprises at least six primary or secondary amino groups
8 . The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of
and a salt thereof;
wherein each A n member is an independently selected CR 5 .
9 . The method of claim 8 , wherein the biocidal polyamine compound is selected from the group consisting of
and a salt thereof; and
wherein R a is an independently selected group of Formula VII:
10 . The method of claim 8 , wherein R a is —CH 2 [NH(CH 2 ) n ] p NH 2 ;
wherein each n is an integer independently selected from 3 to 12; and
wherein each p is an integer independently selected from 1 to 3.
11 . (canceled)
12 . The method of claim 8 , wherein the biocidal polyamine compound is selected from the group consisting of
and a salt thereof.
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . (canceled)
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . (canceled)
21 . (canceled)
22 . The method of claim 1 , wherein the step of treating the biofilm with an anti-biofilm composition effectively disperses the biofilm.
23 . The method of claim 1 , wherein the biofilm comprises an antibiotic-resistant bacterial species.
24 . The method of claim 1 , wherein the method comprises a step of treating a contact lens with the anti-biofilm composition.
25 . The method of claim 1 , wherein the method comprises a step of treating a pipe with the anti-biofilm composition.
26 . The method of claim 1 , wherein the method comprises a step of treating a heating or cooling tower with the anti-biofilm composition.
27 . The method of claim 1 , wherein the method comprises a step of coating an object with the anti-biofilm composition.
28 . The method of claim 1 , wherein the anti-biofilm composition is a paint.
29 . The method of claim 1 , wherein the method comprises a step of treating a patient with a biofilm-related disorder.
30 . A method for inhibiting formation of a biofilm, the method comprising a step of treating planktonic bacteria with an anti-biofilm composition of claim 1 , thereby inhibiting incorporation of the planktonic bacteria into the biofilm.Join the waitlist — get patent alerts
Track US2015274639A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.